by admin | Aug 8, 2025 | Bernie Siegel’s WORLD STEM CELL SUMMIT BLOG, News and Opinions
By Bobby Mukkamala, MD – AMA – For more than a century, NIH-sponsored research has played a critical role in improving the nation’s health. This vital work must continue. It’s not hyperbole to say my sudden brain cancer diagnosis last fall could have put a...
by admin | Aug 7, 2025 | Bernie Siegel’s WORLD STEM CELL SUMMIT BLOG, News and Opinions
by Brittany Cordeiro – Mayo Clinic – ROCHESTER, Minn. — Mayo Clinic has treated the first person in the U.S. using a novel radioactive medicine for advanced breast cancer as part of an international multisite clinical trial. The medicine used in this...
by admin | Aug 6, 2025 | Bernie Siegel’s WORLD STEM CELL SUMMIT BLOG, News and Opinions
By Genectic Engineering & Biotechnology – Phase I clinical trial results suggest that an antibody treatment, used in combination with other drugs, enabled stem cell transplants for three children with Fanconi anemia without toxic busulfan chemotherapy or...
by admin | Aug 5, 2025 | Bernie Siegel’s WORLD STEM CELL SUMMIT BLOG, News and Opinions
By Nature Communications Biology – Adipose tissue-derived mesenchymal stromal/stem cells (ADMSCs) represent a novel therapeutic intervention for Type 1 Diabetes (T1D). The attractiveness of ADMSCs is characterized by their immunomodulatory activities,...
by admin | Aug 4, 2025 | Bernie Siegel’s WORLD STEM CELL SUMMIT BLOG, News and Opinions
By Christy Santhosh – Reuters News – Sarepta Therapeutics (SRPT.O), failed to win the European drug regulator’s backing for its muscle disorder gene therapy on Friday, as the company faces intense regulatory scrutiny after two recent patient deaths...
